Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luigi Gennari

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|May 12, 2004
Ospemifene HormosLuigi Gennari
Expert Opinion on Pharmacotherapy|July 31, 2009
Lasofoxifene, a new selective estrogen receptor modulator for the treatment of osteoporosis and vaginal atrophyLuigi Gennari
Idrugs : the Investigational Drugs Journal|February 8, 2005
Oral ibandronic acidLuigi Gennari
Drugs of Today (Barcelona, Spain : 1998)|July 18, 2006
Lasofoxifene: a new type of selective estrogen receptor modulator for the treatment of osteoporosisLuigi Gennari
Current Opinion in Investigational Drugs (London, England : 2000)|November 2, 2005
Lasofoxifene (Pfizer)Luigi Gennari
Endocrinology and Metabolism Clinics of North America|June 5, 2007
Osteoporosis in menLuigi Gennari, John P Bilezikian
Current Rheumatology Reports|April 18, 2007
Osteoporosis in men: pathophysiology and treatmentLuigi Gennari, John P Bilezikian
Current Osteoporosis Reports|February 27, 2007
Osteoporosis in men: pathophysiology and treatmentLuigi Gennari, John P Bilezikian
Current Osteoporosis Reports|September 21, 2013
Idiopathic osteoporosis in menLuigi Gennari, John P Bilezikian
Expert Opinion on Pharmacotherapy|January 20, 2018
New and developing pharmacotherapy for osteoporosis in menLuigi Gennari, John P Bilezikian
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Current Opinion in Investigational Drugs (London, England : 2000)|May 12, 2004
Ospemifene HormosLuigi Gennari
Expert Opinion on Pharmacotherapy|July 31, 2009
Lasofoxifene, a new selective estrogen receptor modulator for the treatment of osteoporosis and vaginal atrophyLuigi Gennari
Idrugs : the Investigational Drugs Journal|February 8, 2005
Oral ibandronic acidLuigi Gennari
Drugs of Today (Barcelona, Spain : 1998)|July 18, 2006
Lasofoxifene: a new type of selective estrogen receptor modulator for the treatment of osteoporosisLuigi Gennari
Current Opinion in Investigational Drugs (London, England : 2000)|November 2, 2005
Lasofoxifene (Pfizer)Luigi Gennari
Endocrinology and Metabolism Clinics of North America|June 5, 2007
Osteoporosis in menLuigi Gennari, John P Bilezikian
Current Rheumatology Reports|April 18, 2007
Osteoporosis in men: pathophysiology and treatmentLuigi Gennari, John P Bilezikian
Current Osteoporosis Reports|February 27, 2007
Osteoporosis in men: pathophysiology and treatmentLuigi Gennari, John P Bilezikian
Current Osteoporosis Reports|September 21, 2013
Idiopathic osteoporosis in menLuigi Gennari, John P Bilezikian
Expert Opinion on Pharmacotherapy|January 20, 2018
New and developing pharmacotherapy for osteoporosis in menLuigi Gennari, John P Bilezikian
Pageof 14